Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

​ Conditions: SCC – Squamous Cell Carcinoma; Radiotracer; Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Cetuximab (EGFR inhibitor); Drug: 18F-NOTA-ABY-030; Procedure: Positron Emission Tomography (PET)

Sponsors: Vanderbilt-Ingram Cancer Center

Not yet recruiting Conditions: SCC – Squamous Cell Carcinoma; Radiotracer; Head and Neck Squamous Cell Carcinoma; Metastatic Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Cetuximab (EGFR inhibitor); Drug: 18F-NOTA-ABY-030; Procedure: Positron Emission Tomography (PET)
Sponsors: Vanderbilt-Ingram Cancer Center
Not yet recruiting